Q4 2024 Earnings Call Transcript January 23, 2025 Texas Instruments Incorporated beats earnings expectations. Reported EPS is $1.3, expectations were $1.2. Dave Pahl: Welcome to the Texas Instruments Fourth Quarter 2024 Earnings Conference Call.

Analog chip manufacturer Texas Instruments (NASDAQ:TXN) reported Q4 CY2024 results , but sales fell by 1.7% year on year to $4.01 billion. Guidance for next quarter’s revenue was better than expected at $3.

Shares of Texas Instruments Inc and Verizon Communications Inc have been in a sharp downtrend in recent months, but the sell-off has made neither of these any more attractive to own. In fact, Michael Landsberg dubbed both a “value trap” in a recent interview with CNBC.

Texas Instruments announced fourth-quarter earnings above expectations, but highlighted challenges with declining revenues year-over-year.

NASDAQ is losing ground as traders focus on economic data and take profits after the strong rebound from January lows. Texas Instruments, which is down by 7.55%, is the worst performer in the NASDAQ index today. The stock found itself under pressure as traders focused on the disappointing Q1 profit forecast.

Texas Instruments (NASDAQ:TXN) received a reiterated Buy rating and a $250.00 price target from Rosenblatt analysts ahead of its fourth-quarter earnings report, which is scheduled for release after the market closes on January 23,

U.S. stocks edged back from their all-time high as they closed out a second straight winning week. The S&P 500 fell 0.3% on Friday, a day after setting a record. The Dow Jones Industrial Average dropped 0.

Deutsche Bank (ETR:DBKGn) reiterated a Hold rating on Texas Instruments (NASDAQ:TXN) with a steady price target of $200.00, as the stock trades near $197.51. According to InvestingPro data, the company appears overvalued at current levels,

The S&P 500 hit a high. Tesla launched the new Model Y in the U.S. and Europe. AI stocks like Nvidia are testing key levels.

Get Our Latest Stock Analysis on TIGR UP Fintech Stock Up 5.8 % Shares of NASDAQ TIGR opened at $6.91 on Friday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ...

Sanara MedTech (NASDAQ:SMTI – Get Free Report)‘s stock had its “overweight” rating reissued by stock analysts at Cantor Fitzgerald in a note issued to investors on Wednesday,Benzinga reports.